Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasilis Tsimihodimos

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Current Medicinal Chemistry|April 18, 2017
Incretins and Lipid MetabolismVasilis Tsimihodimos, Moses Elisaf
Current Opinion in Lipidology|April 6, 2011
Lipoprotein glomerulopathyVasilis Tsimihodimos, Moses Elisaf
The Open Cardiovascular Medicine Journal|June 11, 2011
Editorial: secondary dyslipidemiasMoses Elisaf, Vasilis Tsimihodimos
European Journal of Pharmacology|October 26, 2017
Effects of incretin-based therapies on renal functionVasilis Tsimihodimos, Moses Elisaf
International Journal of Molecular Sciences|August 10, 2024
Extra Virgin Olive Oil and Metabolic DiseasesVasilis Tsimihodimos, Ourania Psoma
International Journal of Molecular Sciences|April 12, 2022
The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human PathophysiologyAikaterini Dimou, Vasilis Tsimihodimos, Eleni Bairaktari
European Journal of Pharmacology|February 16, 2010
Pleiotropic effects of ezetimibe: do they really exist?Michalis Kalogirou, Vasilis Tsimihodimos, Moses Elisaf
The Open Cardiovascular Medicine Journal|June 7, 2011
Dyslipidemia associated with chronic kidney diseaseVasilis Tsimihodimos, Zoi Mitrogianni, Moses Elisaf
European Journal of Pharmacology|September 22, 2018
SGLT1 inhibition: Pros and consVasilis Tsimihodimos, Sebastien Filippas-Ntekouan, Moses Elisaf
Expert Opinion on Pharmacotherapy|November 12, 2013
Summarizing the FIELD study: lessons from a 'negative' trialVasilis Tsimihodimos, Dimitri P Mikhailidis, Moses Elisaf
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Current Medicinal Chemistry|April 18, 2017
Incretins and Lipid MetabolismVasilis Tsimihodimos, Moses Elisaf
Current Opinion in Lipidology|April 6, 2011
Lipoprotein glomerulopathyVasilis Tsimihodimos, Moses Elisaf
The Open Cardiovascular Medicine Journal|June 11, 2011
Editorial: secondary dyslipidemiasMoses Elisaf, Vasilis Tsimihodimos
European Journal of Pharmacology|October 26, 2017
Effects of incretin-based therapies on renal functionVasilis Tsimihodimos, Moses Elisaf
International Journal of Molecular Sciences|August 10, 2024
Extra Virgin Olive Oil and Metabolic DiseasesVasilis Tsimihodimos, Ourania Psoma
International Journal of Molecular Sciences|April 12, 2022
The Critical Role of the Branched Chain Amino Acids (BCAAs) Catabolism-Regulating Enzymes, Branched-Chain Aminotransferase (BCAT) and Branched-Chain α-Keto Acid Dehydrogenase (BCKD), in Human PathophysiologyAikaterini Dimou, Vasilis Tsimihodimos, Eleni Bairaktari
European Journal of Pharmacology|February 16, 2010
Pleiotropic effects of ezetimibe: do they really exist?Michalis Kalogirou, Vasilis Tsimihodimos, Moses Elisaf
The Open Cardiovascular Medicine Journal|June 7, 2011
Dyslipidemia associated with chronic kidney diseaseVasilis Tsimihodimos, Zoi Mitrogianni, Moses Elisaf
European Journal of Pharmacology|September 22, 2018
SGLT1 inhibition: Pros and consVasilis Tsimihodimos, Sebastien Filippas-Ntekouan, Moses Elisaf
Expert Opinion on Pharmacotherapy|November 12, 2013
Summarizing the FIELD study: lessons from a 'negative' trialVasilis Tsimihodimos, Dimitri P Mikhailidis, Moses Elisaf
Pageof 8